Topic: Novartis AG
The Medical Affairs function arguably plays the most critical role in a biopharmaceutical organization, with heavy responsibilities across areas...
Drug and medical device firm Abbott Laboratories said Friday it has abandoned plans to sell its vaccines unit, less than three months after ...
We'd all like to invest as successfully as the legendary Warren Buffett. He calculates return on invested capital (ROIC) to help determine whether...
Roche says reacting to setbacks, price pressures. . * Analysts see up to 2 bln Sfr in cost savings. . * To announce steps in 2010, implementation...
People who take a commonly used class of osteoporosis drugs called bisphosphonates for more than five years may be doubling their risk of ...
This factbox is part of a special report on the FDA's efforts to regulate drug marketing. The full report can be seen here: link ...
Researchers have discovered a promising new malaria drug with the potential to treat resistant strains of the deadly disease in a single dose, according to a study published Thursday in the journal Science.The drug could be ready for clinical trials as ...
An international team led by scientists from the Scripps Research Institute, the Swiss Tropical Institute, the Genomics Institute of the Novartis...
The Swiss pharmaceutical group Novartis plans to build Latin America's first vaccine factory in Brazil with an investment of 300 to 500 million dollars, the financial daily Valor reported Thursday.The plant, which will be located near the northeastern cit
ZURICH (Reuters) - Swiss drugmaker Novartis AG is pushing ahead with its contentious buyout of Alcon minority shareholders after completing its acquisition of stock from Nestle to get control of the U.S. eyecare group.Novartis, which now holds a 77 per